Month: February 2011

New Blood Test Could Improve Diagnosis and Treatment of Cancer

New blood test technology has been developed that is sensitive enough to detect cancer cells, according to researchers at Massachusetts General Hospital (MGH) and Veridex (a division of Johnson & Johnson). A press release published by Johnson & Johnson suggests the technology, which is currently in development for commercial use, “will enable [circulating tumor cells] …

New Blood Test Could Improve Diagnosis and Treatment of Cancer Read More »

Hormone Receptor Identified as Potential Target for Cancer Treatment

At least 11 common cancers may be partially spurred by the presence of the follicle stimulating hormone (FSH), according to research conducted at the Mount Sinai School of Medicine and France’s National Institute of Health and Medical Research. The findings suggest that cancer treatments that target FSH within cancerous tumors may serve as a viable …

Hormone Receptor Identified as Potential Target for Cancer Treatment Read More »